Sigma-Tau Rare Disease Limited – Trademark Portfolio
Entity Type: 99
Sigma-Tau Rare Disease Limited holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include LEADIANT BIOSCIENCES. The owner is based in London.
21 Holborn Viaduct
London EC1A2DY , GB
Showing of trademarks Trademarks
Trademark Classifications
Sigma-Tau Rare Disease Limited's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Sigma-Tau Rare Disease Limited have?
Sigma-Tau Rare Disease Limited has 6 U.S. trademarks filed with the USPTO. Of these, 1 registered, 5 abandoned.
What trademark classes does Sigma-Tau Rare Disease Limited file in?
Sigma-Tau Rare Disease Limited files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Sigma-Tau Rare Disease Limited's most well-known trademarks?
Sigma-Tau Rare Disease Limited's registered trademark portfolio includes well-known marks such as LEADIANT BIOSCIENCES. These are among 1 currently registered trademark in the portfolio.
What is Sigma-Tau Rare Disease Limited's trademark registration success rate?
Sigma-Tau Rare Disease Limited has a 17% trademark registration rate, with 1 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.